Eclanamine
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C16H22Cl2N2O |
Molar mass | 329.26 g/mol |
3D model (JSmol) | |
| |
|
Eclanamine (U-48,753) is a drug which was patented as an antidepressant, but was never marketed.[1] It acts by inhibiting the reuptake of serotonin and norepinephrine.[2] Eclanamine was discovered by accident as a derivative of the κ-opioid receptor agonist U-50,488.[2]
See also
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.